The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia

Overview of attention for article published in Biologics: Targets & Therapy, March 2008

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial

Article in Caspian Journal of Internal Medicine (January 2022)

Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia)

Article in Integrative Cancer Therapies (May 2016)

B-Cell Disorders and Curcumin

Article in Integrative Cancer Therapies (December 2015)